Market

The cardiovascular research community stood in stunned silence this week as a once-heralded clinical champion stumbled at the very finish line of its long journey toward regulatory approval. Shares of Ionis Pharmaceuticals plummeted by 21% in early trading, while AstraZeneca faced an 8% drop,

The relentless march of Huntington’s disease continues to challenge the limits of modern medicine, functioning as a genetic ticking clock that remains largely unstopped despite decades of intensive research. This genetic disorder represents one of the most daunting frontiers in neurology because no

The rapid expansion of direct-to-consumer medical platforms has fundamentally altered the landscape of mental health services by prioritizing speed and accessibility over the rigorous diagnostic standards historically maintained by traditional brick-and-mortar clinics. This digital transformation,

The landscape of genetic medicine is shifting rapidly as researchers move beyond merely managing the symptoms of chronic conditions to addressing the very foundations of biological dysfunction within the human body. Dravet syndrome represents one of the most challenging forms of epilepsy,

The rapid expansion of the healthcare sector across the Asia-Pacific region has catalyzed a fundamental restructuring of regulatory protocols to ensure that patient safety remains paramount while fostering scientific breakthroughs. As populations age and the demand for cutting-edge treatments like

The traditional model of psychiatric care is facing a dramatic transformation as artificial intelligence evolves from a novelty into a critical pillar of global healthcare infrastructure. While the market was valued at a relatively modest $574 million in 2025, it is now accelerating at a compound